Basic Information
Basic information for SNHG14-333-25aa-1
Peptide Name SNHG14-333-25aa-1
Genome Position chr15:25075832-25075866,25076857-25076896[+]
Species Human
Peptide Sequence MVSFRLVDTSGWWRWHGRKDCVCEG
Peptide Length 25
Unique No (SNHG14-210-25aa-1,SNHG14-224-25aa-2,SNHG14-227-25aa-2,SNHG14-231-25aa-2,SNHG14-235-25aa-2,SNHG14-248-25aa-1,SNHG14-254-25aa-3,SNHG14-268-25aa-2,SNHG14-269-25aa-2,SNHG14-272-25aa-2,SNHG14-282-25aa-2,SNHG14-290-25aa-1,SNHG14-291-25aa-2,SNHG14-299-25aa-1,SNHG14-304-25aa-2,SNHG14-305-25aa,SNHG14-309-25aa-2,SNHG14-318-25aa-1,SNHG14-319-25aa-1,SNHG14-323-25aa-3,SNHG14-332-25aa-3,SNHG14-340-25aa-2)
Grand Average of Hydropathicity -0.448
Relative Molecular Mass 3443.83
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000670542;SNHG14-333
Transcript Length 8250
Coding Ability 0.419
DNA Sequence Corresponding to Peptide ATGGTCTCCTTCAGGCTGGTGGATACCTCAGGATGGTGGCGTTGGCATGGAAGGAAGGACTGTGTCTGTGAGGGA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :